Skip to main content
Top
Published in: Clinical Research in Cardiology 3/2018

01-03-2018 | Original Paper

Electrical cardioversion of patients with implanted pacemaker or cardioverter–defibrillator: results of a survey of german centers and systematic review of the literature

Authors: J. Lüker, A. Sultan, T. Plenge, J. van den Bruck, C.-H. Heeger, S. Meyer, K. Mischke, R. R. Tilz, D. Vollmann, G. Nölker, B. Schäffer, S. Willems, D. Steven

Published in: Clinical Research in Cardiology | Issue 3/2018

Login to get access

Abstract

Aims

A relevant number of patients presenting for electrical cardioversion carry a pacemaker (PM) or ICD. Case reports suggest a potential hazard of external cardioversion/defibrillation. The incidence of shock related device complications is unknown. No guidelines or recommendations by international medical societies for a cardioversion protocol of cardiovascular implantable electronic device (CIED) patients exist. We conducted a nationwide survey to gather real-world clinical data on the current clinical approach towards these patients during electrical cardioversion and to estimate the incidence of shock-related complications.

Methods and results

Ninety hospitals with > 380 ECV in 2014 were identified from mandatory hospital quality reports and 60 were randomly selected. All centers were provided with a standardized questionnaire on the general proceedings and complications during electrical cardioversion of pacemaker, ICD and CRT patients (CIED patients). Thirty-two centers (53%) participated in the survey. In total, 16,554 ECV were reported (534 ± 314 per center). Biphasic cardioversion with a first shock energy of ≥ 150 J via adhesive patches in antero-posterior orientation was preferred by most centers (78%). Eleven percent (n = 1809) of pts were reported to carry a PM/ICD. The ECV protocol was heterogeneous among centers. Complications associated with electrical cardioversion were reported in 11/1809 patients (0.6%), all were transitory elevations of pacing thresholds.

Conclusions

In this nationwide snapshot survey of cardioversion procedures in Germany, approximately 11% of patients presenting for elective electrical cardioversion were pacemaker or ICD carriers. Cardioversion protocols in these patients are heterogeneous throughout centers and mostly not in accordance with recommendation of the German Cardiac Society. Complications associated with external electrical cardioversion are rare. Controlled trials and large registries are necessary to provide evidence for future recommendations.
Literature
1.
go back to reference Swiryn S, Orlov MV, Benditt DG, DiMarco JP, Lloyd-Jones DM, Karst E, Qu F, Slawsky MT, Turkel M, Waldo AL, RATE Registry Investigators (2016) Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes. Circulation 134:1130–1140CrossRefPubMed Swiryn S, Orlov MV, Benditt DG, DiMarco JP, Lloyd-Jones DM, Karst E, Qu F, Slawsky MT, Turkel M, Waldo AL, RATE Registry Investigators (2016) Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes. Circulation 134:1130–1140CrossRefPubMed
2.
go back to reference Israel CW, Neubauer H, Olbrich HG, Hartung W, Treusch S, Hohnloser SH, BEATS Study Investigators (2006) Incidence of atrial tachyarrhythmias in pacemaker patients: results from the balanced evaluation of atrial tachyarrhythmias in stimulated patients (BEATS) study. Pacing Clin Electrophysiol 29:582–588CrossRefPubMed Israel CW, Neubauer H, Olbrich HG, Hartung W, Treusch S, Hohnloser SH, BEATS Study Investigators (2006) Incidence of atrial tachyarrhythmias in pacemaker patients: results from the balanced evaluation of atrial tachyarrhythmias in stimulated patients (BEATS) study. Pacing Clin Electrophysiol 29:582–588CrossRefPubMed
3.
go back to reference Healey JS, Martin JL, Duncan A, Connolly SJ, Ha AH, Morillo CA, Nair GM, Eikelboom J, Divakaramenon S, Dokainish H (2013) Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol 29:224–228CrossRefPubMed Healey JS, Martin JL, Duncan A, Connolly SJ, Ha AH, Morillo CA, Nair GM, Eikelboom J, Divakaramenon S, Dokainish H (2013) Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol 29:224–228CrossRefPubMed
4.
go back to reference Botto GL, Luzi M, Ruffa F, Russo G, Ferrari G (2006) Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data. Pacing Clin Electrophysiol 29(Suppl 2):S48-53PubMed Botto GL, Luzi M, Ruffa F, Russo G, Ferrari G (2006) Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data. Pacing Clin Electrophysiol 29(Suppl 2):S48-53PubMed
5.
go back to reference January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130:2071–2104CrossRefPubMed January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130:2071–2104CrossRefPubMed
6.
go back to reference Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422CrossRefPubMed
7.
go back to reference Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198CrossRefPubMed
8.
go back to reference Das G, Staffanson DB (1997) Selective dysfunction of ventricular electrode-endocardial junction following DC cardioversion in a patient with a dual chamber pacemaker. Pacing Clin Electrophysiol 20:364–365CrossRefPubMed Das G, Staffanson DB (1997) Selective dysfunction of ventricular electrode-endocardial junction following DC cardioversion in a patient with a dual chamber pacemaker. Pacing Clin Electrophysiol 20:364–365CrossRefPubMed
9.
go back to reference Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168CrossRefPubMed
10.
go back to reference Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738CrossRefPubMed
11.
go back to reference Lüker J, von Bodman G, Sultan A, Brömsen J, Akbulak RÖ, Schäffer B, Schreiber D, Hoffmann BA, Block M, Willems S, Steven D (2015) Safety and efficacy of external electrical cardioversion in patients with left ventricular leads. Clin Res Cardiol 104:439–445CrossRefPubMed Lüker J, von Bodman G, Sultan A, Brömsen J, Akbulak RÖ, Schäffer B, Schreiber D, Hoffmann BA, Block M, Willems S, Steven D (2015) Safety and efficacy of external electrical cardioversion in patients with left ventricular leads. Clin Res Cardiol 104:439–445CrossRefPubMed
12.
go back to reference Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263CrossRef
13.
go back to reference Botkin SB, Dhanekula LS, Olshansky B (2003) Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 145:233–238CrossRefPubMed Botkin SB, Dhanekula LS, Olshansky B (2003) Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. Am Heart J 145:233–238CrossRefPubMed
14.
go back to reference Limantoro I, Vernooy K, Weijs B, Pisters R, Debie L, Crijns HJ, Blaauw Y (2013) Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator. Neth Heart J 21:548–553CrossRefPubMedPubMedCentral Limantoro I, Vernooy K, Weijs B, Pisters R, Debie L, Crijns HJ, Blaauw Y (2013) Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator. Neth Heart J 21:548–553CrossRefPubMedPubMedCentral
15.
go back to reference Turco P, D’Onofrio A, Stabile G, Solimene F, La Rocca V, Vecchione F, Iuliano A, Marrazzo N, De Vivo S, Cavallaro C, Bianchi V, Agresta A, Ciardiello C, De Simone A (2012) Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation. J Interv Card Electrophysiol 35:331–336 (discussion 336)CrossRefPubMed Turco P, D’Onofrio A, Stabile G, Solimene F, La Rocca V, Vecchione F, Iuliano A, Marrazzo N, De Vivo S, Cavallaro C, Bianchi V, Agresta A, Ciardiello C, De Simone A (2012) Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation. J Interv Card Electrophysiol 35:331–336 (discussion 336)CrossRefPubMed
16.
go back to reference Sunman H, Aytemir K, Yorgun H, Canpolat U, Yalçin MU, Maharjan N, Asil S, Şahiner L, Kaya B, Özer N, Oto A (2015) Evaluating the efficacy and safety of internal cardioversion with implantable cardioverter defibrillator device for atrial fibrillation in systolic heart failure patients. Ann Noninvasive Electrocardiol 21:181–188CrossRefPubMed Sunman H, Aytemir K, Yorgun H, Canpolat U, Yalçin MU, Maharjan N, Asil S, Şahiner L, Kaya B, Özer N, Oto A (2015) Evaluating the efficacy and safety of internal cardioversion with implantable cardioverter defibrillator device for atrial fibrillation in systolic heart failure patients. Ann Noninvasive Electrocardiol 21:181–188CrossRefPubMed
17.
go back to reference Thijssen J, Borleffs CJ, van Rees JB, Man S, de Bie MK, Venlet J, van der Velde ET, van Erven L, Schalij MJ (2012) Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm 9:513–519CrossRefPubMed Thijssen J, Borleffs CJ, van Rees JB, Man S, de Bie MK, Venlet J, van der Velde ET, van Erven L, Schalij MJ (2012) Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm 9:513–519CrossRefPubMed
18.
go back to reference Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C, Diemberger I, Boriani G (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:1288–1295CrossRefPubMed Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C, Diemberger I, Boriani G (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:1288–1295CrossRefPubMed
19.
go back to reference Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S (2009) Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:1737–1743CrossRefPubMed Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S (2009) Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:1737–1743CrossRefPubMed
20.
go back to reference Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017CrossRefPubMedPubMedCentral Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017CrossRefPubMedPubMedCentral
21.
go back to reference Vamos M, Healey JS, Wang J, Duray GZ, Connolly SJ, van Erven L, Vinolas X, Neuzner J, Glikson M, Hohnloser SH (2016) Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. Heart Rhythm 13:504–510CrossRefPubMed Vamos M, Healey JS, Wang J, Duray GZ, Connolly SJ, van Erven L, Vinolas X, Neuzner J, Glikson M, Hohnloser SH (2016) Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. Heart Rhythm 13:504–510CrossRefPubMed
22.
go back to reference Semmler V, Biermann J, Haller B, Jilek C, Sarafoff N, Lennerz C, Vrazic H, Zrenner B, Asbach S, Kolb C (2015) ICD shock, not ventricular fibrillation, causes elevation of high sensitive troponin T after defibrillation threshold testing–the prospective, randomized, multicentre tropshock-trial. PLoS One 10:e0131570CrossRefPubMedPubMedCentral Semmler V, Biermann J, Haller B, Jilek C, Sarafoff N, Lennerz C, Vrazic H, Zrenner B, Asbach S, Kolb C (2015) ICD shock, not ventricular fibrillation, causes elevation of high sensitive troponin T after defibrillation threshold testing–the prospective, randomized, multicentre tropshock-trial. PLoS One 10:e0131570CrossRefPubMedPubMedCentral
23.
go back to reference Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, Papiashvili G, Dagres N (2017) Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey. Europace 19:660–664CrossRefPubMed Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, Papiashvili G, Dagres N (2017) Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey. Europace 19:660–664CrossRefPubMed
24.
go back to reference Chen J, Lenarczyk R, Boveda S, Richard Tilz R, Hernandez-Madrid A, Ptaszynski P, Pudulis J, Dagres N, Scientific Initiative Committee, European Heart Rhythm Association (2017) Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey. Europace 19:303–307CrossRefPubMed Chen J, Lenarczyk R, Boveda S, Richard Tilz R, Hernandez-Madrid A, Ptaszynski P, Pudulis J, Dagres N, Scientific Initiative Committee, European Heart Rhythm Association (2017) Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey. Europace 19:303–307CrossRefPubMed
Metadata
Title
Electrical cardioversion of patients with implanted pacemaker or cardioverter–defibrillator: results of a survey of german centers and systematic review of the literature
Authors
J. Lüker
A. Sultan
T. Plenge
J. van den Bruck
C.-H. Heeger
S. Meyer
K. Mischke
R. R. Tilz
D. Vollmann
G. Nölker
B. Schäffer
S. Willems
D. Steven
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 3/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1178-y

Other articles of this Issue 3/2018

Clinical Research in Cardiology 3/2018 Go to the issue